Therapeutic Solutions International Inc (TSOI)

[BigBadWolf]

https://www.otcmarkets.com/filing/html?id=15161255&guid=d53wkK4Kn-TCpEh

302 and 906 certification
Companies must file a new Section 302 certification with all amendments to periodic reports. But Section 906 certifications are required only in periodic reports that contain financial statements. So, no new Section 906 certification is required to be filed with amendments that do not contain financial statements.

Note 7 - Notes Payable-Related Party

At June 30, 2021 and December 31, 2020, the Company has unsecured interest-bearing demand notes outstanding to certain officers and directors amounting to $954,962 and $944,098, respectively. Interest accrued on these notes during the six months ended June 30, 2021 and 2020 was $12,956 and $12,956, respectively. Of these, $251,000 are convertible into common stock at prices ranging from $0.004 and $0.005.

Note 8 – Convertible Notes Payable

At various times during the six months ended June 30, 2021, the Company entered into convertible promissory notes with principal amounts totaling $267,250 with a third party for which the proceeds were used for operations. The Company received net proceeds of $252,500, and a $14,750 original issuance discount was recorded. The convertible promissory notes incur interest at 12% per annum and mature on dates ranging from January 25, 2022 to June 14, 2022. The convertible promissory notes are convertible to shares of the Company’s common stock 180 days after issuance. The conversion price per share is equal to 61% of the average of the three (3) lowest trading prices of the Company’s common stock during the fifteen (15) trading days immediately preceding the applicable conversion date. The trading price is defined within the agreement as the closing bid price on the applicable trading market. The Company has the option to prepay the convertible notes in the first 180 days from closing subject to prepayment penalties ranging from 120% to 145% of principal balance plus interest, depending upon the date of prepayment. The convertible promissory notes include various default provisions for which the default interest rate increases to 22% per annum with the outstanding principal and accrued interest increasing by 150%. The Company was required to reserve at June 30, 2021 a total of 286,251,995 common shares in connection with these promissory notes.

https://www.otcmarkets.com/stock/TSOI/disclosure

Q&A
Post by TimGDixon » Wed Nov 10, 2021 12:47 pm

No I won't because thats not what it says at all. We do not comment on filed and published financial statements Cody. The 4 corners speak for themselves. I am telling you this xxxxxx who is spreading those xxxxxxxxxx statements is a damn fool and doesn't understand the first thing about accounting. I'm not forming any opinion I haven't already formed in the filing and then put my signature to under the penalty of perjury and I am telling you and that jackass and anyone else who wants to know its nonsense. Just keep it up. I am not commenting any further on this bull. Hire a lawyer and a CPA and see what they say ok.

xxxxxxxxxxx wrote: ?Wed Nov 10, 2021 12:39 pm
So without judgement, can you clearly explain the financial report stating the 200 million note coming to fruition in 2022?
It’s clearly there, if people are twisting it than correct it, but I don’t see anything not obvious about it, they become unrestricted in 2022 and able to sell, that’s just obvious so what wrong is the thought process of the investors on this subject